Registration
REGISTER FOR THE CONFERENCE
Apply to Exhibit
APPLICATION FOR EXHIBITION
Sponsorship
SPONSORSHIP APPLICATION

Canadian laboratory validates molten salt separation process with real spent fuel, extracting nearly 90% of plutonium in 24 hours
A chemical experiment in Canada involving real commercial reactor spent fuel has achieved noteworthy progress. Canadian Nuclear Laboratories, in shielded hot cells at Chalk River, used irradiated spent fuel from CANDU reactors to validate the first phase of Moltex Energy's waste-to-stable-salt process. The experiment showed that within 24 hours, 89.4% of the plutonium was transferred into the molten salt; by 60 hours, this proportion rose to 94.3%. Meanwhile, the vast majority of uranium remained outside the salt phase, indicating that the process exhibits strong selectivity in separating target elements. This process, named WATSS, is not a plutonium purification route but rather a group separation technology. In addition to large quantities of uranium, spent fuel contains fission products as well as transuranic elements such as plutonium and americium, the latter being a significant source of long-term radiological risk. WATSS uses high-temperature chloride molten salt and specific reducing metals to convert transuranic oxides into salt-soluble forms, while most uranium oxides remain solid. In this experiment, researchers used niobium as the reducing metal; after 24 hours, only 0.05% of uranium entered the salt, dropping to 0.02% after 60 hours, demonstrating that it does not carry large amounts of uranium into the molten salt system.
2026-08-09

Three Los Angeles Companies Race in Portable Nuclear Power Sector
2026-08-09

Finland's Onkalo Repository to Be Commissioned, Experts Say 100,000-Year Safety Assessment Still Faces Uncertainties
2026-08-09

Fluor's Q2 New Orders Surge to $6.1 Billion, Nuclear Fuel Enrichment Projects Boost Backlog to $26.9 Billion
2026-08-09

Russian Company InterPolaris Completes Testing of Heat Exchangers and Mechanical Filters for Nuclear-Powered Icebreakers
2026-08-09

French innovative nuclear company Newcleo submits regulatory engagement plan to NRC for U.S. MOX fuel plant
2026-08-09

Low Danube Water Level Tests Bulgaria's Nuclear Operations, Energy Minister Says Kozloduy Plant Can Sustain Operations for About a Week and a Half
2026-08-08

Russia Offers Brazil Nuclear Technology Cooperation and Small Modular Reactor Projects, Including Floating Nuclear Power Plants and Arctic/Antarctic Scientific Research
2026-08-08

Kazakhstan Atomic Energy Agency and Nazarbayev University Sign Memorandum of Cooperation
2026-08-08

August 5 news, after months of silence, fin whale songs have once again been recorded in the southern Ionian Sea. This observation was jointly completed by multiple experiments connected to the underwater infrastructure of the Southern National Laboratory of the Italian National Institute for Nuclear Physics (LNS-INFN), involving three projects: ITINERIS, LOWNOISER, and VONGOLA. The related work was carried out with the participation of LNS-INFN and the Sicilian Center for Nuclear Physics and Structure of Matter (CSFNSM). The detection occurred in late winter. At that time, the eastern Mediterranean region was affected by strong anthropogenic noise from a long-term geophysical survey of offshore oil and gas resources, and only weeks had passed since the transit of Hurricane Harry. Researchers identified fin whale signals amid the complex acoustic background...
2026-08-09
According to the International Atomic Energy Agency on August 7, research reactors continue to drive innovation in science, medicine, and industry worldwide. Currently, 228 research reactors are in operation across 54 countries, with another 23 under construction or in the planning stage. Unlike nuclear reactors used for power generation, these reactors primarily produce neutrons to support medical, industrial, agricultural, geological, forensic, and nuclear science research. A research reactor pool photographed from above. (Photo: IAEA) In the medical field, research reactors are a vital source of medical radioisotopes. Among them, technetium-99m is widely used for diagnosing cancer and diseases of the heart, brain, and bones; a large number of medical diagnostic and therapeutic procedures worldwide rely on this isotope. Other radioisotopes such as iodine-131 are also used in the treatment of cancer and thyroid diseases. The IAEA states that radioisotopes produced by research reactors serve millions of patients globally and are an essential component of modern nuclear medicine systems.
2026-08-09
On August 7, the first uLinac HalosTx integrated ring-gantry CT linear accelerator in Jiangsu Province was officially put into clinical use at the Third Affiliated Hospital of Nanjing Medical University (Changzhou Second People's Hospital). The system integrates a diagnostic-grade CT scanner and a ring-gantry accelerator on a single platform, shifting regional tumor radiotherapy from the traditional step-by-step positioning approach to a same-platform real-time model. Radiotherapy is one of the important modalities for cancer treatment. In the conventional split-system radiotherapy workflow, patients typically need to be transported between the CT room and the treatment room, and treatment plans are mostly formulated based on static images acquired beforehand. In cases such as tumor regression or changes in patient weight, previous images may not fully reflect the actual condition on the day of treatment...
2026-08-08
On August 7, LifeNuclear, a medical technology startup incubated by the University of Alabama at Birmingham (UAB), announced the launch of TheraGuide, a digital platform designed to help patients undergoing radiopharmaceutical cancer treatment understand and follow radiation safety guidance after discharge. Radiopharmaceutical therapy uses radioactive drugs to target cancer cells while minimizing damage to surrounding healthy tissue. As the therapy's applications expand, patients are typically required to read and follow complex written instructions after treatment, which can be difficult for some patients and caregivers to understand and execute. Dr. Remo George LifeNuclear was founded by UAB...
2026-08-08
The Russian Ministry of Industry and Trade has included the first domestically produced 3D scanner, the RangeVision Helix, in the Unified Register of Russian Electronic Products and the confirmed register of Russian-made industrial products. The registration was carried out in accordance with Russian Government Resolutions No. 878 and No. 719. Thus, the Helix has become the first and currently the only 3D scanner in Russia to be included in the aforementioned national registers. The RangeVision Helix was developed and manufactured by RangeVision, an additive manufacturing partner of Rosatom. Since 2025, the company has become the only Russian 3D scanner manufacturer included in Rosatom's additive manufacturing ecosystem...
2026-08-08
The U.S. Nuclear Regulatory Commission (NRC) plans to hold an online public meeting on August 10 to discuss its proposed rule titled "Reforming and Modernizing the NRC's Radiation Protection Framework." The proposal, published on July 15, centers on reexamining the use of the linear no-threshold model in assessing radiation health effects, as well as the as low as reasonably achievable principle—the ALARA principle—derived from that model. Under the proposal, the NRC intends to remove ALARA-related requirements from its regulations and instead adopt a graded dose management framework. This framework would be based on explicit radiation protection thresholds, dose management methods, and acceptable dose measurement approaches. The regulator stated that this move is not about changing exposure standards for workers and...
2026-08-08
A new study shows that between 2005 and 2023, the rate of dual-energy X-ray absorptiometry (DXA) examinations among U.S. Medicare beneficiaries declined significantly, by 35%. DXA is commonly used for bone density testing and osteoporosis-related screening, and the findings suggest that disparities in screening access across different populations are widening. Researchers analyzed claims data from more than 5 million Medicare beneficiaries. The results showed that DXA utilization fell from 7,255 exams per 100,000 beneficiaries in 2005 to 4,690 per 100,000 beneficiaries in 2023. The study was published in Osteoporosis International. The decline was not uniform across populations...
2026-08-08